TELA Bio

$15.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.98 (-5.99%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TELA Bio and other stocks, options, and ETFs commission-free!

About TELA

TELA Bio, Inc. Common Stock, also called TELA Bio, is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA. The listed name for TELA is TELA Bio, Inc. Common Stock.

CEO
Antony Koblish
Employees
89
Headquarters
Malvern, Pennsylvania
Founded
2012
Market Cap
210.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
29.75K
High Today
$16.41
Low Today
$15.52
Open Price
$16.41
Volume
15.87K
52 Week High
$23.55
52 Week Low
$5.25

TELA Earnings

-$22.58
-$15.05
-$7.53
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, After Hours

You May Also Like

NUO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure